Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

BACKGROUND: Currently, there is no single validated biomarker which can prognosticate survival in patients with stage IV non-small cell lung cancer (NSCLC). This study examines the prognostic significance of four biomarkers: neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Main Authors: Mandaliya, Hiren, Jones, Mark, Oldmeadow, Christopher, Nordman, Ina IC
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6976360/
https://ncbi.nlm.nih.gov/pubmed/32010567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.11.16
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares